Literature DB >> 12831071

Principles of treatment for mammary gland tumors.

C Andrew Novosad1.   

Abstract

The mammary glands are frequent locations for the development of tumors. In the dog and cat, early detection and rapid therapy are necessary to prevent both local and distant metastasis. In the dog, this disease can have a range of biologic behaviors, whereas in the cat it is almost always an extremely aggressive disease. Treatment options depend on tumor staging and can include surgery, radiation therapy, chemotherapy, or a combination. As we become better at early diagnosis and are able to implement aggressive therapy, we are becoming more and more successful in the treatment of this disease. In the following article, we will discuss current thoughts surrounding the diagnosis and treatment options for both canine and feline mammary gland tumors.

Entities:  

Mesh:

Year:  2003        PMID: 12831071     DOI: 10.1053/svms.2003.36625

Source DB:  PubMed          Journal:  Clin Tech Small Anim Pract        ISSN: 1096-2867


  15 in total

1.  Adjuvant Thalidomide and Metronomic Chemotherapy for the Treatment of Canine Malignant Mammary Gland Neoplasms.

Authors:  Cecilia Bonolo DE Campos; Gleidice Eunice Lavalle; Lidianne Narducci Monteiro; Gabriela Rafaela Arantes Pêgas; Silvia Ligório Fialho; Débora Balabram; Geovanni Dantas Cassali
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

2.  Constant Rate Infusion of Lidocaine, Tumescent Anesthesia and Their Combination in Dogs Undergoing Unilateral Mastectomy.

Authors:  Cecilia Vullo; Adolfo Maria Tambella; Annastella Falcone; Gabriele Marino; Giuseppe Catone
Journal:  Animals (Basel)       Date:  2021-04-29       Impact factor: 2.752

3.  Effects of surgical wound infiltration with bupivacaine on postoperative analgesia in cats undergoing bilateral mastectomy.

Authors:  Özge Turna Yilmaz; T Seval Fatma Toydemir; İsmail Kirşan; Banu Dokuzeylul; Zeynep Gunay; Esra Karacam
Journal:  J Vet Med Sci       Date:  2014-09-20       Impact factor: 1.267

4.  Phase I/II clinical trial of encapsulated, cytochrome P450 expressing cells as local activators of cyclophosphamide to treat spontaneous canine tumours.

Authors:  Monika Michałowska; Stanislaw Winiarczyk; Łukasz Adaszek; Wojciech Łopuszyński; Zbigniew Grądzki; Brian Salmons; Walter H Günzburg
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

5.  Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.

Authors:  M R de Araújo; L C Campos; E Ferreira; G D Cassali
Journal:  J Vet Intern Med       Date:  2015-06-30       Impact factor: 3.333

Review 6.  Comparative aspects of microRNA expression in canine and human cancers.

Authors:  Kabiru Sahabi; Gayathri T Selvarajah; Rasedee Abdullah; Yoke Kqueen Cheah; Geok Chin Tan
Journal:  J Vet Sci       Date:  2018-03-31       Impact factor: 1.672

7.  The effects of piroxicam and deracoxib on canine mammary tumour cell line.

Authors:  Fulya Ustün Alkan; Oya Ustüner; Tülay Bakırel; Suzan Cınar; Gaye Erten; Günnur Deniz
Journal:  ScientificWorldJournal       Date:  2012-11-07

8.  Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine.

Authors:  Judit Fazekas; Irene Fürdös; Josef Singer; Erika Jensen-Jarolim
Journal:  Oncol Lett       Date:  2016-08-11       Impact factor: 2.967

9.  BB-Cl-Amidine as a novel therapeutic for canine and feline mammary cancer via activation of the endoplasmic reticulum stress pathway.

Authors:  Melissa M Ledet; Robyn Anderson; Rebecca Harman; Aaron Muth; Paul R Thompson; Scott A Coonrod; Gerlinde R Van de Walle
Journal:  BMC Cancer       Date:  2018-04-12       Impact factor: 4.430

10.  Comparative Analysis of the Development of Acquired Radioresistance in Canine and Human Mammary Cancer Cell Lines.

Authors:  Mark Gray; Arran K Turnbull; James Meehan; Carlos Martínez-Pérez; Charlene Kay; Lisa Y Pang; David J Argyle
Journal:  Front Vet Sci       Date:  2020-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.